Lipella Pharmaceuticals, Inc. (LIPO) Stock Statistics & Valuation Metrics

Lipella Pharmaceuticals, Inc. has a market cap or net worth of $323.46K. The enterprise value is -$1.34M.

Lipella Pharmaceuticals, Inc. has 4,620,837 shares outstanding. The number of shares has decreased by -2.65% in one year.

Lipella Pharmaceuticals, Inc.’s return on equity (ROE) is -2.61 and return on invested capital (ROIC) is -258.28%.

The current PE Ratio of Lipella Pharmaceuticals, Inc. is ―. Lipella Pharmaceuticals, Inc.’s PEG ratio is 0.03.

In the last 12 months, Lipella Pharmaceuticals, Inc. had revenue of 536.36K and earned -5.02M in profits. Earnings per share was -4.79.

In the last 12 months, operating cash flow was -2.36B and capital expenditures 0.00, giving a free cash flow of -2.36B billion.

Lipella Pharmaceuticals, Inc. pays an annual dividend of ―, resulting in a dividend yield of ―

Lipella Pharmaceuticals, Inc. upcoming earnings date is ―, ―.

Lipella Pharmaceuticals, Inc. as a current ratio of 3.47, with Debt / Equity ratio of 17.75%

In the past 12 months, Lipella Pharmaceuticals, Inc. has paid 0.00 in taxes.

Lipella Pharmaceuticals, Inc. EV to EBITDA ratio is -0.21, with an EV/FCF ratio of -0.27.

Lipella Pharmaceuticals, Inc. has $1.86M in cash and marketable securities with $264.08K in debt, giving a net cash position of $1.59M billion.

Gross margin is 0.00%, with operating margin of -947.23%, and net profit margin of -935.25%.

The average price target for Lipella Pharmaceuticals, Inc. is ―, which is 11.43% higher than the current price. The consensus rating is Moderate Buy